R & D Magazine |
A Synthetic Solution Saves Lives
R & D Magazine … a 30-year-old female received a new trachea that was grown using the InBreath bioreactor, created by Harvard Apparatus Regenerative Technology (HART), formerly a division of Harvard Bioscience, marking the first regenerative organ transplant surgery. |
HealthDayNew Drug Combo Might Help Older, Sicker Patients With LeukemiaHealthDayThe researchers, whose study was funded by the manufacturer of both obinutuzumab and rituximab, reported that the obinutuzumab-chlorambucil combination improved outcomes fo…
WDTVJan. 8, 2014 12:01 amNewton KansanCollege and high school blood drives account for as much as 20 percent of donations given through the Red Cross. The entire donation process takes about an hour, but the actual blood donation takes about 10 minutes…
|
Researchers find comparable long-term outcomes between diastolic and systolic …
Medical Xpress A new study by researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) found comparable long-term outcomes between congestive heart failure patients with preserved ejection fraction commonly known as “diastolic … Participation rate problem in rehabStarPhoenix |
Times of India |
‘Dedh Ishqiya’ set to win the audiences heart
Times of India Close. Now visit TOI Tech directly at www.toitech.com · Indiatimes|The Times of India|The Economic Times|. More. More. Follow. ADVERTISEMENT. The Times of India. Bollywood. The Times of India. The Times of India Indiatimes Web (by Google) Video Film Review: ‘Dedh Ishqiya’ not as magical as ‘Ishqiya’, but enjoyableDaily News & Analysis Movie Review: Dedh Ishqiya is worth watching!India Today Amusing, and with a Poetic TouchIndia West |
Novel potential approach to prevent infection in patients with liver failureMedical XpressFindings published in the American Association for the Study of Liver Diseases journal, Hepatology, indicate that infection, the commonest cause of mortality in p…
HealthDay |
Anti-CD20 Antibody + Chemo Benefits CLL With Comorbidity
Monthly Prescribing Reference (HealthDay News) – For patients with previously untreated chronic lymphocytic leukemia (CLL) and coexisting conditions, combining an anti-CD20 antibody (rituximab or obinutuzumab) with chemotherapy is associated with improved outcomes, according to … New Drug Combo Might Help Older, Sicker Patients With LeukemiaHealthDay |
Philly.com |
2-Sizes-Too-Small ‘Grinch’ Effect Hampers Heart Transplantation Success
RedOrbit Current protocols for matching donor hearts to recipients foster sex mismatching and heart size disparities, according to a first-of-its kind analysis by physicians at the University of Maryland School of Medicine. Matching by donor heart size may … Study: 2-sizes-too-small ‘Grinch’ effect hampers heart transplantation successScience Codex Finding the Right Heart for TransplantationdailyRx When it comes to heart transplants, size may matter most14 News WFIE Evansville |
Clinical Hematology Review: Highlights From NEJM, Blood and JCOClinical Oncology NewsUnlike rituximab (Rituxan, Biogen Idec/Genentech), obinutuzumab has no black box warnings. True False; True or False. In a Phase II study published in The New England …
Engineered anti-toxin antibodies improve efficacyScience CodexThe effectiveness of toxin-neutralizing antibodies is considered to be mediated through the interaction of the variable region of the antibody and the toxin; however, recent studies suggest …